Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and B16 Melanoma

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with B16 Melanoma in 2 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prasad, KN2
Cohrs, RJ1
Sharma, OK1
Sahu, SN1

Other Studies

2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and B16 Melanoma

ArticleYear
Decreased expressions of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 1990, Volume: 68, Issue:11

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Butyrates; Butyric Acid; Cell Differentiati

1990
Combined effect of adenosine 3',5'-cyclic monophosphate stimulating agents, vitamin E succinate, and heat on the survival of murine B-16 melanoma cells in culture.
    Cancer, 1988, Sep-01, Volume: 62, Issue:5

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Animals; Cell Survival; Cyclic AMP; Din

1988